Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05791383 · ClinicalTrials.gov registry record · NA

taVNS on the Inpatient Psychiatric Unit

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT05791383 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05791383, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This is a research study to find out if mental health symptoms in patients admitted to the Institute of Psychiatry are affected by a form of ear stimulation called transcutaneous auricular vagus nerve stimulation, or taVNS. Participants will receive ear stimulation during their inpatient treatment at the Institute of Psychiatry. Participants will be randomly assigned to either receive ear stimulation for 1 day (up to 9 treatments over the course of a single day) or 3 days (up to 3 treatments per day), and will have a 50:50 chance of being in either group (like the flip of a coin). Each treatment will last up to 30 minutes and there will be a break of at least 30 minutes in between treatments. The study team will ask participants to complete a group of questionnaires at the beginning and end of the study. In addition, there are several questionnaires that will be completed daily while participants are receiving ear stimulation. Participants in the 1 day stimulation group will also receive 2 days of follow up questionnaires after the initial day of stimulation. The questionnaires will ask questions about mental health symptoms that subjects may or may not be experiencing, including questions about mood, anxiety, and sleep. The ear stimulation treatments will not interfere with the care subjects are receiving from the medical team. In order to qualify for this study, participants must be actively receiving inpatient care at the MUSC Institute of Psychiatry.

Interventions

  • DEVICE transcutaneous auricular neurostimulation

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-12-01
Est. Completion 2024-03-24
Phase NA

What the Registry Record Tells You About NCT05791383

The ClinicalTrials.gov registry entry for NCT05791383 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which transcutaneous auricular neurostimulation is the first listed.

NCT05791383 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05791383 about?

NCT05791383 is a clinical study titled "taVNS on the Inpatient Psychiatric Unit". This is a research study to find out if mental health symptoms in patients admitted to the Institute of Psychiatry are affected by a form of ear stimulation called transcutaneous auricular vagus nerve stimulation, or taVNS. Participants will receive ear stimulation during their inpatient treatment a...

What is the current status of trial NCT05791383?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-12-01. Estimated completion is 2024-03-24.

What interventions are being tested in trial NCT05791383?

The interventions under investigation include: transcutaneous auricular neurostimulation (DEVICE).

Who is sponsoring clinical trial NCT05791383?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.